13
Evidence
THE FDA SCHEDULED A DECEMBER 17 VIRTUAL MEETING OF the “Vaccines and Related Biological Products Advisory Committee,” or VRBPAC, which would spend several hours hearing the evidence behind Moderna’s vaccine, and then vote on whether the FDA should grant emergency-use authorization. FDA officials indicated they would make the final call within days of the December 17 vote, and Secretary of Health and Human Services Alex Azar said distribution of doses would begin as soon as possible after that. Pfizer and BioNTech were still a week ahead and would have their hearing on December 10.1
If all went smoothly, the mass vaccination campaign could begin before Christmas.
To people familiar with the process, a three-week FDA review seemed cartoonishly ...
Get The Messenger now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
